AXAxinet
Menu
Finance

Live market screen

Commercial Space Company Risk / Opportunity Ranking

Opportunity/risk view across launch, satellites, SAR, earth observation, defense demand, financing events, and execution risk.

Updated June 27, 2026

Companies analyzed
438
Ranked rows
876
Evidence links
356
Rows per page
20

Opportunity view

Showing rows 281-300 of 438; 20 rows per page.

Sorted by raw opportunity score
RankCompanyScoreThesis / Evidence
281
Beyond Gravity
lowweak
Opp 1
Risk 1

Thesis: No positive thesis can be supported from these reviewed sources because no direct positive evidence survived the 90-day recent evidence window.

Why now: There is no within the recent evidence window evidence in the reviewed sources for a current catalyst or state change; recency support is absent.

Caveats: The reviewed sources show 8 articles were considered but 0 article IDs remained after recent evidence filtering. Phase-2 membership rationale references: but no article summary or is provided in these reviewed sources, so it cannot be cited as factual support. Scores are kept near zero because direction must come from structured polarity/materiality evidence, which is absent.

282
Blackstar Orbital
lowweak
Opp 1
Risk 1

Thesis: The reviewed sources offers only relation-style context and no direct positive evidence, so there is no supportable opportunity thesis.

Why now: Membership rationale says Starfighters Space expanded technical interchange with Blackstar Orbital (SpaceDrone) in article: but relations are context only and no or direct evidence are provided.

Caveats: Relations marked context-only cannot be used as counterparty propagation evidence. No post-recent evidence window evidence are available. Referenced: has no in the reviewed sources.

283
Canada Rocket Company
lowweak
Opp 1
Risk 1

Thesis: The reviewed sources indicates membership support that Canada Rocket Company was identified as one of three Canadian rocket startups receiving government funding, but no within the recent evidence window direct positive evidence or article summaries are available for scoring, so opportunity evidence is too thin to form a positive thesis from these reviewed sources alone.

Why now: No dated within the recent evidence window scoring evidence is available. The reviewed sources show zero reviewed evidence after recent evidence filtering, so recency-sensitive judgment is not possible from this screen.

Caveats: Phase-2 membership rationale references support article: but the article summary and evidence are not available here, so it cannot be used as direct scoring evidence. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Absence of negative evidence is not positive evidence.

284
Canon Inc.
lowweak
Opp 1
Risk 1

Thesis: The reviewed sources contain no direct positive evidence for Canon within the scoring window. The membership rationale says Canon is mentioned only as one of Rocket Lab's partners/customers in a CubeSat article, which is too incidental to support a company-level opportunity thesis.

Why now: There is no current catalyst in the reviewed sources. Coverage debug shows 863 article IDs considered but 0 after recent evidence window and 0 evidence available after dedupe.

Caveats: Membership rationale references article ID, but no is provided in the reviewed sources, so it cannot be cited as factual scoring evidence under the the evidence standard. Described relevance is only incidental counterparty/customer context.

285
Capella Space
lowweak
Opp 1
Risk 1

Thesis: This reviewed sources slice references only competitive landscape and generic market-report mentions in the phase-2 rationale, with no retained direct positive evidence in the recent evidence window, so there is not enough support for a positive thesis.

Why now: Why now is weak because only 2 articles were considered and none remained after the 90-day recent evidence window; current business-state evidence is absent.

Caveats: Duplicate/slice limitation noted in phase-2 rationale. No recent evidence window-qualified direct evidence. This reviewed sources specifically warns stronger Capella evidence may exist elsewhere, but it is not in this local reviewed sources and cannot be used.

286
Casimir Inc.
lowweak
Opp 1
Risk 2

Thesis: The only possible positive read is from the phase2 rationale, which says Casimir raised a $12M seed round and is tied to a NASA-veteran founder. If accurate, recent financing could support development over a 1 year+ horizon, but the reviewed sources does not include a citable article /summary and also notes the business described is quantum vacuum energy chips rather than a clearly defined target space operating category.

Why now: There is no available article summary or evidence row after recent evidence window, so the only 'why now' is the uncitable phase2 statement about a seed round referenced by article id: without.

Caveats: The reviewed sources itself says the support article is blog commentary, weakening source quality. No citable or summary is provided for the referenced article id No evidence were available after recent evidence window in the served reviewed sources.

287
China Aerospace Science and Technology Corporation
lowweak
Opp 1
Risk 1

Thesis: The reviewed sources does not load any direct positive evidence within the 90-day recent evidence window, so no positive thesis is supported.

Why now: No current ranking evidence is available: evidence recent evidence review no current evidence was retained and coverage data shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Membership rationale cites contextual mention of CASC via article, but unavailable in reviewed sources.

Caveats: Only contextual mention is described in membership rationale. No evidence available after recent evidence filtering. Referenced has no in the reviewed sources.

288
China Rocket
lowweak
Opp 1
Risk 1

Thesis: The reviewed sources does not retain sufficient direct positive evidence for a durable opportunity thesis.

Why now: The membership rationale says Jielong 3 is by CASC subsidiary China Rocket and cites article, but support is described as only a brief article-context mention and no retained evidence row or is provided after recent evidence window.

Caveats: Support is explicitly called provisional single-article context in the reviewed sources. No retained evidence are available.

289
China Spacesat
lowweak
Opp 1
Risk 1

Thesis: The reviewed sources only says an opinion piece listed China Spacesat among global space companies, with no direct facts or events specific to the company retained after recent evidence window, so there is no evidence basis for a positive thesis.

Why now: No within the recent evidence window catalyst or business-state change is documented. The reviewed sources show zero retained evidence after recent evidence window.

Caveats: Phase-2 rationale references: but no or retained article summary is provided. Support is described as provisional single-article context only. Coverage debug shows no retained evidence.

290
Chunghwa Telecom Co., Ltd.
lowweak
Opp 1
Risk 1

Thesis: No positive thesis is supportable from the retained reviewed sources evidence because there is no direct positive evidence after recent evidence window.

Why now: Why now is weak: the reviewed sources show zero retained evidence after recent evidence window, so there is no current catalyst or business-state confirmation in the evidence provided.

Caveats: Phase-2 membership rationale references: and says Astranis has new satellite projects with Chunghwa Telecom launching later in 2026, but no article summary or retained quoted evidence is included here, and relations are context-only unless separately policy-gated. Coverage after recent evidence window is empty for this company.

291
Clear Space
lowweak
Opp 1
Risk 1

Thesis: The reviewed sources only indicates that Clear Space develops space lidars in a space or aerospace context. That is not enough to support a meaningful positive thesis over a 1 year+ horizon without current financing, contracts, or milestone evidence.

Why now: There is no strong why-now support because no evidence were available after recent evidence window; current operating or financing status is unconfirmed in the reviewed sources.

Caveats: No in-window evidence are available. Membership rationale itself notes the evidence is sparse and does not explicitly establish on-orbit servicing in these reviewed sources. Recency is unconfirmed.

292
Collins
lowweak
Opp 1
Risk 1

Thesis: The reviewed sources notes many mentions tied mainly to RTX/Raytheon and market lists, but does not cleanly establish 'Collins' as a target company with direct positive business evidence in the recent evidence window.

Why now: There is no usable timing evidence. Despite large article count, coverage data shows 0 articles after recent evidence window and 0 evidence after recent evidence window, and no are provided for cited support article ids or.

Caveats: High mention volume is not conviction and cannot substitute for company-specific evidence. The reviewed sources itself flags insufficiently established entity identity and role. No representative articles or are available for citation despite many articles considered.

293
Comtech Telecommunications Corp.
lowweak
Opp 1
Risk 1

Thesis: No positive thesis can be supported from these reviewed sources because no direct positive evidence or representative article summaries are provided within the recent evidence window.

Why now: There is no usable company-specific evidence in the reviewed sources after recent evidence filtering; coverage data shows zero article IDs after recent evidence window and zero evidence available, so there is no current catalyst basis in these reviewed sources.

Caveats: Absence of evidence is not positive evidence. Reviewed evidence notes only weak peer-group context in phase2 rationale, but no citable article details are included in the scoring fields.

294
Cosmoserve
lowweak
Opp 1
Risk 1

Thesis: The reviewed sources rationale weakly suggests possible opportunity because Cosmoserve is mentioned among Indian space-tech startups and the article notes product-technologies including satellite communications. But the reviewed sources does not directly describe Cosmoserve's own business or provide a citable article summary/ in the recent evidence window.

Why now: No in-recent evidence window article summary or evidence row was available for Cosmoserve, so there is no supported catalyst timing.

Caveats: The mention is article-level and indirect rather than company-specific. Phase2 rationale references article id: but no or summary is included. No direct evidence were available after recent evidence window.

295
Cosmoserve Space
lowweak
Opp 1
Risk 1

Thesis: The company is described in membership rationale as participating in debris removal and RPOD-related activity, but no retained 90-day direct positive evidence supports a forward opportunity thesis.

Why now: The reviewed sources retains zero evidence after the recent evidence filter, leaving no current catalyst or recency-supported business update.

Caveats: Only one historical article was considered and none are retained within the recent evidence window. The single membership support item is not enough for a current directional call. This is effectively a watchlist placeholder until newer evidence appears.

296
Digantara
lowweak
Opp 1
Risk 1

Thesis: The membership rationale suggests funding and space situational awareness relevance, but the served reviewed sources retains no 90-day positive evidence to support a long-horizon opportunity thesis.

Why now: Despite several historical mentions, the reviewed sources show zero retained article IDs and zero evidence after recent evidence filtering, so there is no recent catalyst evidence in the served data.

Caveats: Historical support mentions approximately $50M funding, but the underlying evidence is not retained within the current recent evidence window reviewed sources. Low scores reflect missing current evidence, not a negative operating judgment.

297
Digantara
lowweak
Opp 1
Risk 1

Thesis: The reviewed sources indicates Digantara is relevant to space situational awareness and references a missile tracking satellite, which could imply strategic relevance, but there is no usable in-window article or evidence available for directional scoring.

Why now: There is no strong 'why now' because coverage data shows zero article IDs after recent evidence window and zero evidence after recent evidence window, so any thesis would be under-supported for current timing.

Caveats: No evidence remained after the 90-day recent evidence window. Phase-2 membership rationale is not enough for a directional thesis by itself. Recency and business-state claims are unavailable in the reviewed sources.

298
DPhi Space
lowweak
Opp 1
Risk 1

Thesis: Only a minimal opportunity view is possible because the phase2 rationale says DPhi Space was using Solstar's Deke system and was identified as Swiss, implying some active space-company involvement. But the reviewed sources explicitly says the business fit remains indirect and thin.

Why now: No available article summaries or evidence exist after recent evidence window for DPhi Space in these reviewed sources, so there is no supported why-now catalyst.

Caveats: Support level is only provisional_single_article_context in the reviewed sources. Phase2 rationale references article id, but no or summary is included. No evidence were available after recent evidence window.

299
EarthDaily
lowweak
Opp 1
Risk 2

Thesis: The reviewed sources membership rationale says EarthDaily received an NRO contract for EO/IR under Strategic Commercial Enhancements, which could support a long-horizon government-demand opportunity, but no within the recent evidence window evidence or article details were available to substantiate the claim for ranking use in this screen.

Why now: Why now is weak because the reviewed sources show zero evidence kept within the 90-day recent evidence window for ranking, making recency and business-state assessment uncertain.

Caveats: Phase-2 membership rationale references: but no or available evidence row is provided in these reviewed sources. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Cannot treat cohort membership as thesis attractiveness.

300
Elbit Systems Ltd.
lowweak
Opp 1
Risk 1

Thesis: Despite broad defense and space-adjacent relevance in the membership rationale, the reviewed sources have no direct positive evidence within the recent evidence window, so no positive 1 year+ thesis is supportable.

Why now: Membership rationale references articles: and, but coverage data shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. unavailable in reviewed sources.

Caveats: Large mention volume is not conviction. Defense-space context is not directional proof. Referenced have no in the reviewed sources.

Risk view

Showing rows 361-380 of 438; 20 rows per page.

Sorted by raw risk score
RankCompanyScoreThesis / Evidence
361
Safran
lowweak
Opp 1
Risk 1

Thesis: The reviewed sources also does not provide direct adverse evidence within the available 90-day evidence set, so there is no basis for a material risk thesis beyond uncertainty from missing evidence coverage.

Why now: There is no current catalyst in the reviewed sources. Coverage debug shows 270 article IDs considered but 0 article IDs after recent evidence window and 0 evidence available after dedupe, so recency-based thesis formation is not supported.

Caveats: Membership rationale references article IDs 2026-04, and, but no are provided in the reviewed sources, so they cannot be cited as factual scoring evidence under the the evidence standard. Evidence recent evidence review shows 0 kept rows after the 90-day cutoff.

362
Sanyark Space Technologies
lowweak
Opp 2
Risk 1

Thesis: No direct negative evidence is available. Risk is mainly that accelerator inclusion alone is too weak to support a durable company thesis, especially over a 1 year+ horizon without proof of funding, contracts, or product milestones (: not provided in reviewed sources).

Why now: There is no supported timing edge because the reviewed sources have zero direct evidence after recent evidence window and no dated article details beyond the structure.

Caveats: Accelerator participation is weaker than company-specific funding or contract evidence. The article appears to describe a cohort rather than a company-specific event. No, quote, or direct event row is available.

363
SatLeo Labs
lowweak
Opp 1
Risk 1

Thesis: No material adverse evidence is available in the reviewed sources.

Why now: No retained within the recent evidence window evidence are provided, so there is no reviewed sources-supported why-now beyond cohort inclusion rationale.

Caveats: Only membership rationale is available; no citeable retained evidence. Small-company universe but zero available evidence after recent evidence window.

364
SatVu
lowweak
Opp 2
Risk 1

Thesis: No retained within the recent evidence window direct negative evidence is provided in the reviewed sources.

Why now: There is no usable within the recent evidence window evidence after filtering; the only cited article is older than the March 29, 2026 cutoff and therefore not timely support for a 1 year+ ranking under these reviewed sources' evidence policy.

Caveats: The reviewed sources report zero kept rows after recent evidence window for SatVu. Older funding evidence exists but was dropped by policy, so recency is insufficient for a stronger score.

365
Scale AI
lowweak
Opp 2
Risk 1

Thesis: The risk case is limited by lack of direct adverse evidence in the reviewed sources; the primary risk is evidentiary rather than operational because no retained post-recent evidence window event details, award sizing to the company, or execution milestones are available.

Why now: Why now is muted because the reviewed sources references support article in membership rationale, but no, article summary, or retained evidence after the 90-day filter are available to confirm timing or scope.

Caveats: Despite 273 articles considered, coverage data shows articles after recent evidence window 0 and evidence after recent evidence window 0. The contract claim is only present in membership rationale citing article without a in the served reviewed sources. Opportunity score is kept low because the the evidence standard require direct positive evidence, not just membership inclusion.

366
Schaeffler AG
lowweak
Opp 2
Risk 1

Thesis: No material negative evidence is available within the reviewed sources recent evidence window. Risk remains low on evidence, not necessarily in reality.

Why now: No surviving 90-day evidence are available despite 94 articles considered. The only support is the membership rationale reference to: but the reviewed sources provide no and no retained evidence.

Caveats: Membership rationale is not sufficient directional proof. No direct positive or negative evidence survived the recent evidence window. Industrial-partner status versus core space-company status is unclear from the reviewed sources.

367
SciTec
lowweak
Opp 1
Risk 1

Thesis: No material negative evidence is retained, leaving no evidence-based risk case.

Why now: No current catalyst is established because the reviewed sources retains no company-specific evidence after the 90-day filter.

Caveats: Phase-2 rationale references, but no or retained summary is available in the reviewed sources. Support level is provisional single-article context. No direct company-specific positive or negative evidence remain after recent evidence window.

368
SEALCOIN AG
lowweak
Opp 2
Risk 1

Thesis: No material adverse evidence is retained.

Why now: The membership rationale says SEALCOIN secured strategic investment for space-based blockchain infrastructure leveraging a satellite constellation, tied to article: but no or retained evidence are present after recent evidence window.

Caveats: Only rationale-level description is available; no retained direct evidence row with is supplied. The business category fit is ambiguous in the reviewed sources itself.

369
SEALSQ Corp
lowweak
Opp 1
Risk 1

Thesis: The reviewed sources also provides no retained material adverse evidence, leaving risk unsupported beyond baseline uncertainty.

Why now: There is no usable current evidence because articles after recent evidence window = 0 and evidence after recent evidence window = 0 following the March 29, 2026 cutoff.

Caveats: No surviving recent evidence window-qualified evidence. Space relevance in reviewed sources rationale does not establish direction.

370
SES S.A.
lowweak
Opp 1
Risk 1

Thesis: No material adverse evidence is available for SES. Risk score remains low because of lack of evidence, not because risk has been disproven.

Why now: Why-now is weak because no reviewed evidence are available after recent evidence window, so recency and catalysts cannot be assessed from the reviewed sources.

Caveats: Membership rationale references and, but no corresponding available article summaries or evidence are provided. Coverage debug shows articles after recent evidence window 0 and evidence after recent evidence window 0. Cohort membership does not establish opportunity.

371
Sidus Space Inc.
lowweak
Opp 1
Risk 1

Thesis: No within the recent evidence window direct negative evidence was available, so the reviewed sources does not support a material risk thesis.

Why now: There is no retained dated company evidence after the 90-day recent evidence window; timing support for a 1 year+ thesis is absent in the reviewed sources.

Caveats: Coverage is effectively empty after recent evidence window: articles after recent evidence window = 0 and evidence after recent evidence window = 0. The membership rationale mentions article IDs, and, but no or retained evidence content are provided in these reviewed sources.

372
SkyFi
lowweak
Opp 1
Risk 1

Thesis: No direct negative evidence is available, so there is no supportable downside thesis from these reviewed sources alone.

Why now: Membership rationale says SkyFi was mentioned as a commercial access partner for Vantor's satellite imagery constellation in article, but this is only contextual and no or direct evidence are provided.

Caveats: Partner context is weaker than direct company evidence. No evidence available after recent evidence filtering. Referenced has no in the reviewed sources.

373
Skyfora
lowweak
Opp 1
Risk 1

Thesis: There is no retained direct adverse evidence in the reviewed sources after recent evidence window, so any risk thesis would be speculative rather than evidence-based.

Why now: No within the recent evidence window company-specific catalyst is provided. The reviewed sources reports zero reviewed evidence after the 90-day cutoff for Skyfora, so recency is insufficiently grounded.

Caveats: Phase-2 rationale references a €6.5M raise tied to: but no representative article, or retained evidence row is provided in these reviewed sources, so it cannot be used as direct scored evidence. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Membership review status is not directional proof.

374
Solestial Inc.
lowweak
Opp 1
Risk 1

Thesis: No material adverse thesis is supportable from these reviewed sources because no retained direct negative evidence is provided inside the recent evidence window.

Why now: No current catalyst can be established from the reviewed sources; the company has zero evidence after recent evidence window.

Caveats: Phase-2 rationale says York Space Systems acquired Solestial and cites: but no article summary or is provided here, so it cannot be used as cited factual support. Coverage debug shows 4 articles considered and 0 article IDs after recent evidence window. Absence of evidence is not positive or negative proof.

375
Solstar Space Company
lowweak
Opp 1
Risk 1

Thesis: No material negative evidence is available, so there is no supported adverse thesis from the evidence provided.

Why now: The reviewed sources contain no reviewed evidence after recent evidence window for this company, preventing a recency-based 1 year+ ranking judgment beyond watchlist status.

Caveats: Membership rationale references article, but no direct summary or evidence row is available here for citation. Coverage debug shows zero available evidence after recent evidence window. Private-company status is not itself positive or negative.

376
Space Mission Systems
lowweak
Opp 2
Risk 1

Thesis: No direct negative evidence is available. The main risk is identity ambiguity and insufficient grounding rather than a demonstrated adverse development.

Why now: The only potential 'why now' is contract-related context in the membership rationale, but it is not sufficiently tied to this entity and no dated scoring evidence with is available.

Caveats: Membership rationale references article ID: but no is provided in the reviewed sources, so it cannot be cited as factual scoring evidence under the the evidence standard. Entity identification is unclear in the reviewed sources.

377
Space Systems/Loral, LLC (SSL)
lowweak
Opp 1
Risk 1

Thesis: No direct adverse evidence is available in the reviewed sources, so risk stays low purely due to missing evidence rather than demonstrated resilience.

Why now: No current catalyst can be established because coverage debug shows 0 article IDs after recent evidence window and 0 evidence after recent evidence window. The rationale cites: without a in these reviewed sources.

Caveats: Only industry-report context is referenced in membership rationale. No direct event/fact evidence survived the recent evidence window.

378
Space42
lowweak
Opp 1
Risk 1

Thesis: No retained adverse evidence is provided, so there is no material evidence-based risk thesis in these reviewed sources.

Why now: Why now is weak because coverage data shows no articles after recent evidence window and no evidence after recent evidence window.

Caveats: Membership rationale references article IDs but no are provided, so they cannot be used as cited factual support here. Coverage debug shows articles after recent evidence window 0 and evidence after recent evidence window 0.

379
Spaceflux
lowweak
Opp 3
Risk 1

Thesis: No material negative evidence is available. The main risk is that the cited funding amount may be too small to be strategically meaningful, but the reviewed sources does not provide direct adverse evidence or enough detail to rank this as a strong risk name (: not provided in reviewed sources).

Why now: A follow-on investment could matter over 1 year+ if it extends development in debris tracking, but there is no available dated evidence within the recent evidence window and no direct article summary/ in the reviewed sources.

Caveats: Only article-level rationale is available. Funding size may be modest, but reviewed sources does not provide enough context to judge materiality precisely. No representative article or quote available.

380
SpaceLocker
lowweak
Opp 1
Risk 1

Thesis: There is not enough retained evidence in the recent evidence window to support a material risk thesis.

Why now: No article-level or event-level evidence were retained after the March 29, 2026 recent evidence window cutoff; recency for the membership rationale is therefore unusable for ranking.

Caveats: Membership rationale references article, but no representative article summary or retained evidence row is included. Single-article universe with zero retained rows limits confidence materially.